Overview

A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects

Status:
Withdrawn
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This study is a 4 period study to see if there is any interaction between Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Thai Adult Subjects
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Oseltamivir
Zanamivir